Talundzic Eldin, Plucinski Mateusz M, Biliya Shweta, Silva-Flannery Luciana M, Arguin Paul M, Halsey Eric S, Barnwell John W, Vannberg Fredrik, Udhayakumar Venkatachalam
Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Atlanta Research and Education Foundation, Veterans Affairs Medical Center, Atlanta, Georgia, USA
Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA President's Malaria Initiative, Atlanta, Georgia, USA.
Antimicrob Agents Chemother. 2016 May 23;60(6):3821-3. doi: 10.1128/AAC.00171-16. Print 2016 Jun.
The rapid emergence of drug-resistant malaria parasites during the course of an infection remains a major challenge for providing accurate treatment guidelines. This is particularly important in cases of malaria treatment failure. Using a previously well-characterized case of malaria treatment failure, we show the utility of using next-generation sequencing for early detection of the rise and selection of a previously reported atovaquone-proguanil (malarone) drug resistance-associated mutation.
在感染过程中耐药疟原虫的迅速出现仍然是提供准确治疗指南的一项重大挑战。这在疟疾治疗失败的病例中尤为重要。利用一个先前已充分表征的疟疾治疗失败病例,我们展示了使用新一代测序技术早期检测先前报道的与阿托伐醌-氯胍(malarone)耐药相关突变的出现和选择的效用。